Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors – rationale and design of the “Beyond-SMuRFs Study”

[1]  A. Papazoglou,et al.  The SMuRFs and the SMuRF-Less Gargamel. , 2022, JACC. Cardiovascular interventions.

[2]  Chen Wang,et al.  Prognostic performance of multiple biomarkers in patients with acute coronary syndrome without standard cardiovascular risk factors , 2022, Frontiers in Cardiovascular Medicine.

[3]  G. Sianos,et al.  Association of stress induced hyperglycemia with angiographic findings and clinical outcomes in patients with ST-elevation myocardial infarction , 2022, Cardiovascular Diabetology.

[4]  G. Sianos,et al.  Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors , 2022, Frontiers in Cardiovascular Medicine.

[5]  Yi Wang,et al.  Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry , 2022, BMC Medicine.

[6]  K. Nasir,et al.  Socioeconomic status, cardiovascular risk profile, and premature coronary heart disease , 2022, American journal of preventive cardiology.

[7]  G. Gallo,et al.  Myocardial Infarction in Patients Without Cardiovascular Risk Factors: Advanced Prediction Models to Unlock the Clinical Dilemma? , 2022, JACC. Cardiovascular interventions.

[8]  C. Granger,et al.  Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors. , 2022, JACC. Cardiovascular interventions.

[9]  W. Cubała,et al.  Commentary concerning treatment of depression in patients with heart failure according to 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2022, European journal of preventive cardiology.

[10]  H. Gika,et al.  Prognostic significance of metabolomic biomarkers in patients with diabetes mellitus and coronary artery disease , 2022, Cardiovascular Diabetology.

[11]  A. Donato,et al.  Trends and Outcomes of ST-Segment-Elevation MI in Hospitalized Patients Without Standard Modifiable Cardiovascular Risk Factors. , 2022, Current problems in cardiology.

[12]  G. Figtree,et al.  Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors , 2022, Frontiers in Cardiovascular Medicine.

[13]  Chi‐Hang Lee,et al.  Prognostic Outcomes in Acute Myocardial Infarction Patients Without Standard Modifiable Risk Factors: A Multiethnic Study of 8,680 Asian Patients , 2022, Frontiers in Cardiovascular Medicine.

[14]  G. Giannakoulas,et al.  Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation , 2022, Cardiovascular Diabetology.

[15]  E. Theodorsson,et al.  Standard Modifiable Cardiovascular Risk Factors Mediate the Association Between Elevated Hair Cortisol Concentrations and Coronary Artery Disease , 2022, Frontiers in Cardiovascular Medicine.

[16]  L. Angelis,et al.  A Risk-Stratification Machine Learning Framework for the Prediction of Coronary Artery Disease Severity: Insights From the GESS Trial , 2022, Frontiers in Cardiovascular Medicine.

[17]  Hanxion Liu,et al.  Standard Modifiable Cardiovascular Risk Factors and Prognosis of Acute Coronary Syndrome in Younger Patients. , 2021, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[18]  I. V. Van Gelder,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.

[19]  C. Thorup,et al.  Patient-reported outcomes, sociodemographic and clinical factors are associated with 1-year mortality in patients with ischemic heart disease—findings from the DenHeart cohort study , 2021, Quality of Life Research.

[20]  Zuyi Yuan,et al.  Targeted metabolomic analysis of plasma fatty acids in acute myocardial infarction in young adults. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[21]  G. Figtree,et al.  Coronary artery disease patients without standard modifiable risk factors (SMuRFs)- a forgotten group calling out for new discoveries. , 2021, Cardiovascular research.

[22]  C. Arvanitidis,et al.  Current clinical applications and potential perspective of micro-computed tomography in cardiovascular imaging: A systematic scoping review. , 2021, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[23]  M. T. Lønnebakken.  The risk of no risk in STEMI , 2021, The Lancet.

[24]  E. Hagström,et al.  Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data , 2021, The Lancet.

[25]  G. Theodoridis,et al.  Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial , 2021, BMC Cardiovascular Disorders.

[26]  M. Dorobanțu,et al.  Inflammatory markers in acute myocardial infarction and the correlation with the severity of coronary heart disease , 2021, Annals of medicine.

[27]  Steffen E. Petersen,et al.  2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2016, European journal of preventive cardiology.

[28]  OUP accepted manuscript , 2021, European Journal of Preventive Cardiology.

[29]  Sathish Kumar Jayapal,et al.  Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.

[30]  A. Bardají,et al.  The absence of standard modifiable cardiovascular risk factors does not predict better outcomes in patients with acute coronary syndrome , 2020 .

[31]  Panos Vardas,et al.  European Society of Cardiology: Cardiovascular Disease Statistics 2019. , 2019, European heart journal.

[32]  R. Schnabel,et al.  Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population. , 2019, European journal of preventive cardiology.

[33]  V. Regitz-Zagrosek,et al.  Sex differences in cardiometabolic disorders , 2019, Nature Medicine.

[34]  G. Figtree,et al.  ST‐Segment–Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors—How Common Are They, and What Are Their Outcomes? , 2019, Journal of the American Heart Association.

[35]  G. Figtree,et al.  Utilizing state‐of‐the‐art “omics” technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease , 2018, Microcirculation.

[36]  C. Thorup,et al.  Mental health is a risk factor for poor outcomes in cardiac patients: Findings from the national DenHeart survey. , 2018, Journal of psychosomatic research.

[37]  K. Channon,et al.  Metabolomic Profiling in Acute ST‐Segment–Elevation Myocardial Infarction Identifies Succinate as an Early Marker of Human Ischemia–Reperfusion Injury , 2018, Journal of the American Heart Association.

[38]  Scott B. Crown,et al.  Cardiovascular Metabolomics , 2018, Circulation research.

[39]  M. Ward,et al.  Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors , 2017, European journal of preventive cardiology.

[40]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.

[41]  M. Farag,et al.  A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction , 2016, Scientific Reports.

[42]  B. V. Van Tassell,et al.  Inflammatory markers in ST-elevation acute myocardial infarction , 2016, European heart journal. Acute cardiovascular care.

[43]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[44]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[45]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[46]  P. Mills,et al.  A Meta-Analysis of Mental Health Treatments and Cardiac Rehabilitation for Improving Clinical Outcomes and Depression Among Patients With Coronary Heart Disease , 2013, Psychosomatic medicine.

[47]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[48]  Jan Gunnar Fjeld,et al.  A novel clinical method for quantification of regional left ventricular pressure–strain loop area: a non-invasive index of myocardial work , 2012, European heart journal.

[49]  World Medical Association (WMA),et al.  Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.

[50]  Frederick P Roth,et al.  Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.

[51]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[52]  Ilse De Bourdeaudhuij,et al.  Addressing overreporting on the International Physical Activity Questionnaire (IPAQ) telephone survey with a population sample , 2003, Public Health Nutrition.

[53]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[54]  P. Ridker,et al.  Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.